Luotai Xuesaitong Soft capsule was selected into the guidelines for community prevention and treatment of cerebrovascular disease

It is reported that the revision of the guidelines lasted for nearly two years, bringing together a number of experts in related fields. Based on the first edition of the guidelines for community prevention and treatment of cerebrovascular diseases, the guidelines updated the analysis of high-risk groups and risk factors of cerebrovascular diseases in recent years, providing more and more effective strategies and methods in the prevention of cerebrovascular diseases. The guidelines will provide community doctors with guidance on the prevention and treatment of cerebrovascular diseases, so that they can have rules to follow in the prevention, first aid, rehabilitation, nursing and referral of cerebrovascular diseases, so as to improve their diagnosis and treatment level. According to the characteristics of patients’ syndromes, the acute injury stage and the coexisting stage of injury and repair of cerebral infarction can be divided into phlegm heat syndrome, phlegm dampness syndrome, Qi deficiency syndrome and yin deficiency syndrome according to the characteristics of patients’ syndromes, and the symptomatic treatment is based on stages and types. Xuesaitong for injection can be used in the concurrent period of injury and repair. Because blood stasis is common in all types, it is not listed as one type. The clinical treatment is based on the western medicine of hypoglycemic, lipid-lowering and antiplatelet aggregation. According to the characteristics of syndrome types, Xuesaitong Soft capsule can be added. The indications, pharmacological effects and use methods of Luotai Xuesaitong Soft Capsule were described in detail in the reference table of common clinical drugs. < p > < p > in the past 70 years, Kunlun medicine has been promoting the inheritance, innovation and high-quality development of traditional Chinese medicine in an important position, adhering to the combination of integrity and innovation, and actively expanding the development direction of traditional Chinese medicine in the new era. As the leader of Panax notoginseng innovation technology, Luotai Xuesaitong has played an important role in the prevention and treatment of cardiovascular and cerebrovascular diseases. The inclusion of the guidelines provides a powerful tool for grass-roots doctors to manage the risk factors of cerebrovascular diseases, which can further promote the standardized management of cerebrovascular diseases at the grass-roots level, and will better promote the use of traditional Chinese medicine in the management of chronic diseases at the grass-roots level.